Nitric Oxide Donators for Sebum Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current acne treatments, particularly those targeting sebum production, often come with adverse effects such as dryness, irritation, and severe side effects, and there is a need for new medications that can effectively reduce sebum production without these drawbacks.
Innovation Solution
Applying nitric oxide or nitric oxide-releasing compounds, such as N-diazeniumdiolate-functionalized polysiloxane macromolecules and nitrosothiol-functionalized compounds, directly or indirectly to the skin to decrease sebum production, thereby reducing acne.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current acne treatments (topical retinoids, antibiotics, oral contraceptives) are used to address acne pathogenic factors, then antimicrobial and anti-inflammatory effects are achieved, but dryness, irritation, and peeling of the skin occur
Solution Approach 1:
The patent uses nitric oxide as an intermediary substance that mediates between the treatment goal (reducing acne) and minimizing harm (avoiding dryness and irritation). Nitric oxide donators deliver nitric oxide to the skin, which then modulates sebaceous gland activity and reduces inflammation without causing the harsh side effects of traditional treatments like retinoids and antibiotics.
Solution Approach 2:
The patent changes the chemical parameter by introducing nitric oxide donators (compounds that release nitric oxide) as a new class of acne treatment. This represents a fundamental shift from using antibiotics, retinoids, or hormonal treatments to using nitric oxide-releasing compounds, thereby changing the mechanism of action and side effect profile.
2Reliability
If oral retinoid isotretinoin is used to affect all four pathogenic factors of acne, then comprehensive acne treatment is achieved, but severe side effects occur including teratogenicity, depression, psychosis, and suicide
Solution Approach 1:
The patent applies nitric oxide locally to the skin rather than systemically throughout the body. By using topical nitric oxide donators, the treatment targets sebaceous glands and acne pathogenic factors at the site of application, achieving local therapeutic effects without the severe systemic side effects of oral isotretinoin.
Solution Approach 2:
Nitric oxide serves as a local intermediary that can modulate multiple acne pathogenic factors (sebaceous gland activity, inflammation, bacterial growth) without requiring systemic absorption. This local mediation achieves comprehensive acne treatment while avoiding the teratogenic and psychiatric side effects of oral retinoids.
3Quantity of substance
If topical treatments are applied to reduce sebum production, then acne symptoms are addressed, but dryness and peeling of the skin result
Solution Approach 1:
The patent changes the approach to sebum reduction by using nitric oxide donators that release nitric oxide, which naturally regulates sebaceous gland activity. This differs from traditional treatments that aggressively dry out the skin, instead providing a more physiological modulation of sebum production that avoids excessive dryness and peeling.
Data Source
AI summary
Provided herein are methods of using gaseous nitric oxide and/or at least one nitric oxide source to or decrease sebum production in the skin of a subject. In some embodiments, the nitric oxide source includes small molecule and/or macromolecular NO-releasing compounds.